PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmultiple myeloma
MeSH D009101 - multiple myeloma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008232:Lymphoproliferative disorders
2 Companies
2 Drugs
$
Success rate
D010265:Paraproteinemias
1 Company
1 Drug
$
Success rate
D020141:Hemostatic disorders
1 Company
1 Drug
$
Success rate
D054219:Plasma cell neoplasms
1 Company
1 Drug
$
Success rate
D009101: 
Multiple myeloma
80 Companies
34 Drugs
$
Success rate
D007952:Plasma cell leukemia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBortezomib Bortezomib  2022-05-02   
Cyclophosphamide Neosar  1993-04-29   
Pomalidomide Pomalidomide  2022-05-04   
Zoledronic acid Zoledronic acid Teva  2012-08-16   
Zoledronic acid Zoledronic acid Teva Generics  2014-03-27   
Zoledronic acid Zoledronic acid Teva Pharma  2012-08-15   
Plerixafor Plerixafor  2023-07-24   
Cisplatin Cisplatin  2000-05-16   
IngenusCarmustine Carmustine  2022-06-21   
Cyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Melphalan Melphalan  2020-02-18   
MylanBortezomib Bortezomib  2022-10-31   
Lenalidomide Lenalidomide  2022-08-30   
Lenalidomide Lenalidomide Mylan  2020-12-18   
Melphalan Melphalan  2009-06-09   
Pomalidomide Pomalidomide  2022-01-26   
Zoledronic acid Zoledronic Acid  2013-03-04   
Zoledronic acid Zoledronic acid Mylan  2012-08-23   
Carmustine Carmustine  2023-03-03   
Cisplatin Cisplatin  2012-04-18   
Johnson & JohnsonCiltacabtagene autoleucel Carvykti  2022-02-28 $499 M Y2023 
Daratumumab Darzalex  2015-11-16 $9,744 M Y2023 
Daratumumab, Hyaluronidase Darzalex Faspro  2020-05-01   
Teclistamab Tecvayli  2022-10-25   
Bortezomib Velcade  2004-04-26 $408 M Y2020 
Talquetamab Talvey  2023-08-09   
GSKBelantamab mafodotin Blenrep  2020-08-05   
RocheRibavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
Interferon alfa-2a Roferon-A  1986-06-04   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
Lenalidomide Lenalidomide  2022-09-06   
SandozZoledronic acid Aclasta  2005-04-15   
Bortezomib Bortezomib  2022-07-26   
Zoledronic acid Reclast 2023-10-27 2007-04-16   
Cyclophosphamide Cyclophosphamide  2023-09-12   
NovartisZoledronic acid Zometa 2025-05-29 2001-08-20   
SanofiPlerixafor Mozobil 2023-07-22 2008-12-15   
Isatuximab Sarclisa  2020-03-02   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
76%
194/255
Phase 2
35%
96/272
Phase 3
47%
83/176
Approved: 52Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cyclophosphamide,
Cisplatin,
DELANZOMIB,
Beeam
Johnson & Johnson
Bortezomib,
Daratumumab,
Hyaluronidase,
Ciltacabtagene autoleucel,
Teclistamab,
Hyaluronidase (human recombinant),
Talquetamab,
Belantamab,
Mafodotin,
Benzocaine,
Vitamin e,
Iberdomide,
Cetrelimab,
Calcium dobesilate,
Terfenadine,
Vorhyaluronidase alfa,
Sodium lactate,
Zoptarelin doxorubicin,
Microcrystalline cellulose
GSK
Belantamab mafodotin,
BELANTAMAB MAFODOTIN-BLMF,
Belantamab,
Mafodotin,
Docusate,
Iberdomide,
Feladilimab,
Calcium dobesilate,
Astuprotimut-r,
Sodium chloride,
Veltuzumab,
Gsk3174998,
Belamaf
Roche
Ribavirin,
Peginterferon alfa-2a,
Interferon alfa-2a,
Iberdomide,
Rimiducid,
CEVOSTAMAB,
Ro6870810
Sandoz
Tbo-filgrastim,
Lenograstim,
Regramostim
Novartis
Zoledronic acid,
Benzocaine,
Tbo-filgrastim,
Antithrombin iii,
Aglatimagene besadenovec,
Spartalizumab,
Lenograstim,
Dovitinib,
Alanine,
Vatalanib,
Calcium dobesilate,
Phenylalanine,
Regramostim,
Sodium chloride,
Sodium lactate,
AFURESERTIB,
LUCATUMUMAB,
Microcrystalline cellulose,
Vob560,
Bhq880,
Lcl161,
Mik665,
Whg626,
Lgh447,
Cjm112
Sanofi
Isatuximab,
Plerixafor,
ISATUXIMAB-IRFC,
Belantamab,
Mafodotin,
Mycophenolate sodium,
Tbo-filgrastim,
Antithrombin iii,
Iberdomide,
Lenograstim,
Calcium dobesilate,
Regramostim,
Terfenadine
Merck Sharp & Dohme
Ribavirin,
Interferon alfa-2b,
Peginterferon alfa-2b,
Belantamab,
Mafodotin,
Antithrombin iii,
Dinaciclib,
Ridaforolimus,
Calcium dobesilate,
Sodium chloride,
DALOTUZUMAB,
Zoptarelin doxorubicin
Pfizer
Bortezomib,
Zoledronic acid,
Elranatamab,
Tbo-filgrastim,
Iberdomide,
Lenograstim,
Figitumumab,
Tacedinaline,
Calcium dobesilate,
Regramostim,
FILANESIB
Takeda
Bortezomib,
Ixazomib,
Belantamab,
Mafodotin,
Docusate,
Antithrombin iii,
Calcium dobesilate,
Phenylalanine,
Alfacalcidol,
Sodium ascorbate,
MEZAGITAMAB,
MODAKAFUSP ALFA,
Retinol,
TAK-981,
TAK-573
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use